AstraZeneca resumes Covid vaccine trial after UK nod - RTHK
A A A
Temperature Humidity
News Archive Can search within past 12 months

AstraZeneca resumes Covid vaccine trial after UK nod

2020-09-12 HKT 22:04
Share this story facebook
  • The company says the UK committee has concluded its investigations and recommended that trials in the country are safe to resume. File photo: Reuters
    The company says the UK committee has concluded its investigations and recommended that trials in the country are safe to resume. File photo: Reuters
Drugs giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.

"Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so," the company said in a statement.

The late-stage trials of the experimental vaccine, one of the most advanced in development, were suspended this week after an illness in a study subject in Britain.

"The standard review process triggered a voluntary pause to vaccination across all global trials to allow review of safety data by independent committees, and international regulators," AstraZeneca said.

"The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume."

The company said it could not disclose further medical information.

"All trial investigators and participants will be updated with the relevant information and this will be disclosed on global clinical registries, according to the clinical trial and regulatory standards." (AFP, Reuters)